These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 27529389)
1. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator. Nagra B; Awan MU; Miriyala V; Kantharia BK Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389 [No Abstract] [Full Text] [Related]
2. "Train tracks" and "step ladders" on implantable cardioverter defibrillator interval plot in a patient with dual tachycardia: Putting the dots together. Saini A; Ellenbogen KA; Tan A; Kaszala K; Huizar JF Pacing Clin Electrophysiol; 2017 Nov; 40(11):1298-1301. PubMed ID: 28901551 [No Abstract] [Full Text] [Related]
3. Are electrophysiological studies needed before implantable cardioverter defibrillator surgery? Böcker D; Block M; Borggrefe M; Breithardt G Eur Heart J; 1997 Apr; 18(4):548-51. PubMed ID: 9129880 [No Abstract] [Full Text] [Related]
4. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome. De Maria E; Cappelli S; Cappato R Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298 [No Abstract] [Full Text] [Related]
5. Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation. Otto L; Mann DE; Kelly PA; Reiter MJ Pacing Clin Electrophysiol; 1999 Oct; 22(10):1550-2. PubMed ID: 10588160 [TBL] [Abstract][Full Text] [Related]
6. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism? Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856 [No Abstract] [Full Text] [Related]
7. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation]. Siebels J; Schneider MA; Kuck KH Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289 [TBL] [Abstract][Full Text] [Related]
9. Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment. Chinushi M; Washizuka T; Kasai H; Ohhira K; Satoh M; Aizawa Y Jpn Circ J; 1999 Dec; 63(12):1007-10. PubMed ID: 10614851 [TBL] [Abstract][Full Text] [Related]
10. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS. Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513 [TBL] [Abstract][Full Text] [Related]
11. Electrical storm and implanted defibrillators. Davis CP South Med J; 2007 May; 100(5):547-8. PubMed ID: 17534103 [No Abstract] [Full Text] [Related]
12. Augmented QRS notching and macroscopic T-wave alternans preceding polymorphic ventricular tachycardia in a patient with electrical storm. Minatoguchi S; Takasugi N; Kubota T; Ushikoshi H; Nishigaki K; Minatoguchi S Europace; 2017 Apr; 19(4):643. PubMed ID: 28339622 [No Abstract] [Full Text] [Related]
13. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915 [TBL] [Abstract][Full Text] [Related]
14. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH; Yee R; Jung W J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117 [TBL] [Abstract][Full Text] [Related]
15. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child. Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320 [No Abstract] [Full Text] [Related]
16. [How do we treat an electrical storm in implantable cardioverter defibrillator (ICD) appropriate patients?]. Özin B Turk Kardiyol Dern Ars; 2014 Jun; 42(4):417. PubMed ID: 25112002 [No Abstract] [Full Text] [Related]
17. Coronary artery spasm as a cause of ST elevation and inappropriate implantable cardioverter defibrillator intervention. Mascioli G; Bontempi L; Racheli M; Cerini M; Curnis A; Cas LD J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1055-7. PubMed ID: 18163021 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy. Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288 [TBL] [Abstract][Full Text] [Related]
19. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems]. Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246 [TBL] [Abstract][Full Text] [Related]
20. [Malignant fascicular ventricular tachycardia degenerating into ventricular fibrillation in a patient with early repolarization syndrome]. Kane A; Defaye P; Jacon P; Mbaye A; Machecourt J Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):292-5. PubMed ID: 21665187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]